[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416-346-7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 5.03, "open": 4.5, "dayLow": 2.36, "dayHigh": 4.6799, "regularMarketPreviousClose": 5.03, "regularMarketOpen": 4.5, "regularMarketDayLow": 2.36, "regularMarketDayHigh": 4.6799, "payoutRatio": 0.0, "beta": 0.216, "trailingPE": 0.05651341, "volume": 2084395, "regularMarketVolume": 2084395, "averageVolume": 755987, "averageVolume10days": 4099490, "averageDailyVolume10Day": 4099490, "bid": 1.97, "ask": 2.81, "bidSize": 2, "askSize": 2, "marketCap": 1683227, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 345.0, "fiftyDayAverage": 5.42132, "twoHundredDayAverage": 14.757905, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5966969, "profitMargins": 0.0, "floatShares": 66425, "sharesOutstanding": 713232, "sharesShort": 12872, "sharesShortPriorMonth": 15310, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.018, "heldPercentInsiders": 0.00483, "heldPercentInstitutions": 0.49685, "shortRatio": 0.28, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 713232, "bookValue": 94.317, "priceToBook": 0.025021998, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.631, "52WeekChange": -0.9923773, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 2.36, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754092793, "regularMarketTime": 1754078400, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -53.0815, "regularMarketPrice": 2.36, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "postMarketChangePercent": 68.6441, "postMarketPrice": 3.98, "postMarketChange": 1.62, "regularMarketChange": -2.67, "regularMarketDayRange": "2.36 - 4.6799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 755987, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "2.36 - 345.0", "fiftyTwoWeekHighChange": -342.64, "fiftyTwoWeekHighChangePercent": -0.9931595, "fiftyTwoWeekChangePercent": -99.23773, "epsTrailingTwelveMonths": 41.76, "fiftyDayAverageChange": -3.06132, "fiftyDayAverageChangePercent": -0.5646817, "twoHundredDayAverageChange": -12.397905, "twoHundredDayAverageChangePercent": -0.84008574, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "prevName": "Psyence Therapeutics Corp.", "nameChangeDate": "2025-07-27", "cryptoTradeable": false, "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]